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Developing motor axons induce synaptic specializations in muscle ®bers, including preferential transcription of acetylcho-
line receptor (AChR) subunit genes by subsynaptic nuclei. One candidate nerve-derived signaling molecule is AChR-
inducing activity (ARIA)/heregulin, a ligand of the erbB family of receptor tyrosine kinases. Here, we asked whether ARIA
and erbB kinases are expressed in patterns compatible with their proposed signaling roles. In developing muscle, ARIA
was present not only at synaptic sites, but also in extrasynaptic regions of the muscle ®ber. ARIA was synthesized, rather
than merely taken up, by muscle cells, as indicated by the presence of ARIA mRNA in muscle and of ARIA protein in a
clonal muscle cell line. ARIA-responsive myotubes expressed both erbB2 and erbB3, but little EGFR/erbB1 or erbB4. In
adults, erbB2 and erbB3 were localized to the postsynaptic membrane. ErbB3 was restricted to the postsynaptic membrane
perinatally, at a time when ARIA was still broadly distributed. Thus, our data are consistent with a model in which ARIA
interacts with erbB kinases on the muscle cell surface to provide a local signal that induces synaptic expression of AChR
genes. However, much of the ARIA is produced by muscle, not nerve, and the spatially restricted response may result from
the localization of erbB kinases as well as of ARIA. Finally, we show that erbB3 is not concentrated at synaptic sites in
mutant mice that lack rapsyn, a cytoskeletal protein required for AChR clustering, suggesting that pathways for synaptic
AChR expression and clustering interact. q 1995 Academic Press, Inc.
INTRODUCTION 1995; Apel and Merlie, 1995). Recent studies on all three
signaling pathways are providing a view of transynaptic sig-
naling that may be relevant to other synaptic componentsWhen motor axons innervate muscle ®bers, they induce
formation of a specialized postsynaptic membrane, the best and to other synapses (Hall and Sanes, 1993).
Here, we focus on the pathway by which axons inducestudied component of which is the nicotinic acetylcholine
receptor (AChR). In adult muscle, AChRs are present at AChR expression. Studies on adult muscle have shown that
this signal acts locally. RNAs that encode AChR subunits⁄10,000/mm2 in the synaptic membrane, but their density
falls to £10/mm2 in extrasynaptic membrane (Salpeter and (Merlie and Sanes, 1985; Fontaine et al., 1988; Goldman and
Staple, 1989; Brenner et al., 1990) and other synapse-speci®cHarris, 1983; Salpeter et al., 1988). The nerve appears to use
at least three distinct mechanisms to achieve this striking proteins (Michel et al., 1994; Moscoso et al., 1995) are highly
concentrated in synaptic areas. Moreover, reporter genes linkedlocalization. First, axons release factors that stimulate syn-
thesis of AChRs in the synaptic portion of the muscle ®ber to AChR genomic fragments are selectively expressed by sub-
synaptic nuclei in transgenic mice, providing direct evidence(Chu et al., 1995b). Second, nerve-evoked electrical activity
represses synthesis of AChRs in extrasynaptic areas (Laufer for the unique transcriptional potential of synaptic nuclei
(Klarsfeld et al., 1991; Sanes et al., 1991; Simon et al., 1992).and Changeux, 1989). Third, nerve-derived clustering fac-
tors such as agrin cause aggregation of receptors already A plausible hypothesis is that a local signal released by axons
acts on a receptor in the postsynaptic membrane to induce orpresent in the membrane, via association with the AChR-
associated cytoskeletal protein, rapsyn (Bowe and Fallon, maintain the special properties of the underlying nuclei.
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A leading candidate for the nerve-derived signal is ARIA. 1994), rat erbB2 (Bargmann et al., 1986), human erbB3
Based on studies showing that neural extracts stimulated (Kraus et al., 1989; Plowman et al., 1990), and human erbB4
AChR synthesis in aneural myotubes (Cohen and Fischbach, (Plowman et al., 1993a). Primer sequences were chosen
1977; Jessell et al., 1979), an AChR-inducing activity (ARIA) from regions in which the four sequences were minimally
was puri®ed from chicken brain (Usdin and Fischbach, 1986) related (30% amino acid identity for any pair). First-strand
and shown to induce expression of AChR subunit genes (Har- cDNA was generated by reverse transcription of RNA iso-
ris et al., 1988; Martinou et al., 1991; Chu et al., 1995a; Jo et lated from mouse brain and Sol 8 myotubes. The cDNA
al., 1995). When cDNAs encoding the protein were isolated was then subjected to PCR, and ampli®ed fragments were
(Falls et al., 1993), sequence analysis revealed that ARIA is subcloned into Bluescript II (SK/) (Stratagene, LaJolla, CA).
encoded by the same gene that generates proteins that had Multiple clones for each fragment were sequenced. Each
been isolated as ligands of the neu protooncogene (heregulin mouse sequence isolated was closely related to its human
or NDF; Holmes et al., 1992; Wen et al., 1992) and as a glial ortholog but clearly distinct from the other three erbB se-
growth factor (Marchionni et al., 1993). In situ hybridization quences (Fig. 1). Thus, each of the four characterized human
revealed that ARIA mRNA is present in embryonic motor erbB genes has a clear murine counterpart.
neurons (Falls et al., 1993; Marchionni et al., 1993), and immu- For ARIA, primers were designed using the rat NDF se-
nohistochemistry showed that ARIA-like immunoreactivity quence (Wen et al., 1992), and DNA was ampli®ed as above.
is present at synaptic sites in adult muscle (Chu et al., 1995a; Primer sequences are as follows: EGFR 5*, GATGCT-
Jo et al., 1995). Thus, ARIA/heregulin is a candidate neural GATGAGTATCTTATCCCACAGC; EGFR 3*, GGTCTC-
inducer of AChR synthesis. TTCCAGGAGCTGGATGCAGGG; erbB2 5*, TGGACA-
Although the mechanism by which ARIA acts is un- GTACCTTCTACCGTTCACTGC TGGA; erbB2 3*, GGG-
known, its identity with heregulin and NDF suggests that
GTCCTCGCTGTACCGCTGTAGAGGGCT; erbB3 5*,its receptors are related to neu. Neu, also called erbB2 or
TCTGGATACATGCCCATGAACCAGGGTAATCTTGG;HER2, is a receptor tyrosine kinase related to the epidermal
erbB3 3*, CCTTTGAGGTGTGTATCTGGCATGACATAAgrowth factor receptor (EGFR or erbB1; Bargmann et al.,
CC; erbB4 5*, CTCTTGGATGAAGAGGATTTGGAAGAT-1986). Additional members of this family, erbB3/HER3 and
ATGATGGA; erbB4 3*, CTTGCGTAGGGTGCCATTACA-erbB4/HER4, have also been cloned (Kraus et al., 1989;
GCAGGAGTCATC; ARIA 5*A, TCTGGAGAGTATATG-Plowman et al., 1990, 1993a). Heregulins have been reported
TGCAAAGTGATCAGC; ARIA 5*B, ACATCAACATCCACto bind to and activate erbB2±erbB4 in numerous cell types
GACTGGGACCAGCCATCT; ARIA 3*, GCAGTAGGC-(Plowman et al., 1993b; Carraway et al., 1994; Sliwkowski
CACCACACACATGATGCC.et al., 1994; Tzahar et al., 1994; reviewed in Carraway and
Cantley, 1994) and to induce tyrosine phosphorylation of
both erbB2 and erbB3 in cultured myotubes (Jo et al., 1995). Animals and Cells
Thus, erbB2 and/or erbB3 are candidate receptors for ARIA.
Adult male and timed pregnant female Wistar rats wereThe present studies were undertaken to learn whether ARIA
obtained from Harlan Sprague±Dawley (Indianapolis, IN).and erbB kinases are expressed in vivo at sites and times consis-
For surgery, rats were anesthetized by intraperitoneal injec-tent with their playing roles as nerve-derived signal and mus-
tion of ketamine (8.7 mg/100 g) and xylazine (13 mg/100 g).cle-associated receptor, respectively, for transcriptional activa-
Rat lower leg muscles were denervated by unilateral sectiontion of synaptic nuclei. We asked which erbB kinases muscle
cells express and determined the distribution of ARIA and of the sciatic nerve in the upper thigh. At appropriate times
the erbB kinases in developing, adult, denervated, and mutant thereafter, the rats were euthanized with methoxy¯uorane
muscles. Several of our results suggest modi®cations to current and the tibialis anterior and extensor digitorum longus mus-
views on the involvement of ARIA and erbB kinases in nerve± cles were dissected. Unoperated legs served as controls.
muscle interactions. First, synapse-associated ARIA is synthe- Generation and characterization of mice with targeted
sized by muscle cells as well as by motoneurons, suggesting mutations in the Rapsn (Gautam et al., 1995) and LamB2 (s-
that ARIA may act in part by an autocrine mechanism. Second, laminin/laminin b2) genes (Noakes et al., 1995) have been
erbB2 and erbB3 are selectively associated with the postsynap- described elsewhere. Heterozygotes were bred to generate
tic membrane, suggesting that the spatial restriction of the homozygotes, which were identi®ed by PCR. Wild-type and
signaling pathway may re¯ect the localization of the receptor heterozygote littermates were used as controls.
as well as of its ligand. Finally, the synaptic localization of Sol 8 cells (Mulle et al., 1988) were maintained in log
erbB3 requires rapsyn, which is also necessary for the agrin- phase growth by trypsinization and replating in DMEM con-
dependent clustering of AChRs. Thus, the ARIA and agrin taining 20% fetal calf serum on gelatin-coated plates. For
signaling pathways may interact. RNA isolation, cells were allowed to reach con¯uence and
switched to low-serum differentiation medium, as de-MATERIALS AND METHODS scribed in Chu et al. (1995a). A bacterially produced recom-
Cloning of EGFR, erbB2, erbB3, erbB4, and ARIA binant heregulin fragment, rHRGb1177±244 (3 nM; Holmes et
Fragments al., 1992), a generous gift of Mark Sliwkowski (Genentech),
was added 24 hr later, and myotube cultures were harvestedOligonucleotide primers were designed that corresponded
to cytoplasmic regions of mouse EGFR (Luetteke et al., 48 hr later.
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FIG. 1. cDNA probes for mouse erbB2-4. (a) Amino acid sequences of PCR products cloned from Sol 8 cells (mouse) were aligned with
corresponding human sequences. Amino acid identity is indicated with vertical bars. (b) Similarity between mouse and human erbB
sequences. Each mouse gene has a clear human counterpart. Accession numbers for mouse erbB2-4 sequences are L47239±41.
Immunohistochemistry anti-mouse) were obtained from Boehringer-Mannheim (In-
dianapolis, IN) and Sigma (St. Louis, MO).
Rabbit antibodies to EGFR (sc-03), erbB2 (sc-284), erbB3 Light microscopic immunohistochemical methods were
(sc-285), erbB4 (sc-283), and their respective blocking pep- modi®ed from Covault and Sanes (1986). In brief, cryostat
tides were obtained from Santa Cruz Biotechnology (Santa sections of un®xed muscle were incubated with antibody
Cruz, CA). A second rabbit antibody to erbB3 was purchased diluted in a solution of bovine serum albumin (10 mg/ml)
from Transduction Laboratories (Lexington, KY). Antibod- in phosphate-buffered saline (PBS), either overnight at 47C
ies to recombinant heregulin, provided by Mark Sliwkow- or for 3 hr at room temperature. The sections were washed,
ski, were described previously (Chu et al., 1995a). This anti- incubated with a ¯uorescein-conjugated secondary anti-
serum was used in most studies reported here, but where body, and washed again. Sections were mounted with para-
noted, immunohistochemical results were con®rmed with phenyldiamine and glycerol and viewed with epi¯uores-
rabbit antisera to a peptide derived from the carboxy termi- cence optics. To identify synaptic sites, sections were dou-
nus of a human heregulin precursor (sc-348; Santa Cruz bly stained either with rhodamine-a-bungarotoxin, which
Biotechnology). To reduce background staining, antisera binds to acetylcholine receptors in the postsynaptic mem-
were sometimes incubated at 47C for 2 hr with a particulate brane, or with SV2, which stains synaptic vesicles in nerve
fraction from adult rat muscle. Particulate matter was re- terminals.
moved by centrifugation before staining. Antibody to SV2
was a gift of Kathleen Buckley (Harvard Medical School),
RNA Analysisrhodamine-a-bungarotoxin was purchased from Molecular
Probes (Eugene, Oregon), and ¯uorescein-conjugated second Myotube RNA was isolated by the method of Chomczyn-
ski and Sacchi (1987) as modi®ed by Xie and Rothblumantibodies (goat anti-rabbit, donkey anti-sheep, and goat
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(1991). Lengths of cloned PCR products used for templates
were: EGFR, 328 bp, linearized with HindIII; erbB2, 350 bp,
linearized with StyI; erbB3, 350 bp, linearized with HindIII;
erbB4, 273 bp, linearized with BamHI; and heregulin, 492
bp, linearized with HindIII. RNA was obtained by transcrip-
tion with T3 or T7 RNA polymerase (Promega, Madison,
WI), using 12.5 mM [33P]UTP or [32P]UTP, for in situ hybrid-
ization or RNase protection, respectively, to label tran-
scripts.
RNase protection analysis was performed as described by
Miner and Wold (1991). Brie¯y, RNA prepared from tissues
or cultured cells was hybridized overnight with 5 1 109
molecules of [32P]cRNA at 507C in 80% formamide, 40 mM
Pipes, 400 mM NaCl, and 1 mM EDTA. Samples of 300 ml
were then digested with 120 ng of RNase A (Sigma) and 300
units of RNase T1 (USB, Cleveland, OH), followed by 40 mg
proteinase K, and then electrophoresed on an 8% acryl-
amide 7.5 M urea gel. Finally, the gel was exposed to XAR-
5 ®lm (Kodak, Rochester, NY).
In situ hybridization was performed as described by Mos-
coso et al. (1995), using 33P-labeled probes. The AChR e
subunit probe described by Moscoso et al. (1995) was used
as a positive control. A laminin a1 subunit (Sasaki et al.,
1988) probe was used as a negative control, based on RNase FIG. 2. ARIA is associated with nerve terminals in adult muscle.
Sections of normal (a, b), 2-day denervated (c), or 12-day denervatedprotection studies showing that this subunit is not ex-
(d) muscle was stained with antibodies to recombinant heregulin.pressed at detectable levels in muscle (J. Miner and J.R.S.,
Sections were counterstained with anti-SV2 to label nerve termi-unpublished). After sections were hybridized, slides were
nals (a*) or with rhodamine-a-bungarotoxin to label the postsynap-exposed to XAR-5 ®lm for 3 days.
tic membrane (b*±d*). In adult muscle, ARIA is present in nerve
terminals as well as in association with the postsynaptic membrane
and/or basal lamina. Axotomy leads to loss of axon- and terminal-Immunoblotting
associated ARIA, but muscle-associated ARIA persists. Bar, 15 mm
Tissues and cells were solubilized in modi®ed Laemmli for a and 40 mm for b±d.
(1970) buffer. Samples were separated on a 6 or 7.5% SDS±
polyacrylamide gel and transferred onto nitrocellulose
membrane (0.45 mm, Schleicher & Schuell). Transfer was
structures that were also labeled by antibodies to the synap-carried out in 96 mM glycine, 12.5 mM Tris, 20% (vol/vol)
tic vesicle protein SV2 (Figs. 2a and 2a*) and that directlymethanol for 2 hr at 400 mA. Membranes were blocked
apposed the rhodamine-a-bungarotoxin-stained postsynap-overnight at 47C in 5% nonfat dry milk in PBS/0.5% Tween
tic membrane (Figs. 2b and 2b*). Most of the punctate ARIA20. Primary antibodies were diluted in 2.5% nonfat dry milk
immunoreactivity was lost within 2 days of axotomy (Fig.in PBS/0.5% Tween 20. Horseradish peroxidase-conjugated
2c), but signi®cant ARIA remained associated with synapticgoat anti-rabbit (Boehringer-Mannheim) or donkey anti-
sites for at least 12 days (Fig. 2d), indicating that some issheep (Sigma) secondary antibodies were used at 1:2000.
also associated with the muscle cell surface or synapticImmunoreactive species were detected using a chemilumi-
cleft.nescence reagent according to the manufacturer's instruc-
Next, we asked when ARIA becomes concentrated at syn-tions (DuPont NEN, Boston, MA).
aptic sites. ARIA immunoreactivity was detectable at syn-
aptic sites by P0 (Fig. 3a). Surprisingly, however, the ARIA
was not con®ned to synaptic sites, but extended aroundRESULTS
much of the circumference of the muscle ®ber. Moreover,
anti-ARIA also stained the muscle ®ber cytoplasm and/orExpression of ARIA in Extrasynaptic Regions of
intracellular membranes. Staining of muscle ®bers in-Developing Muscle
creased during the ®rst several postnatal days (Fig. 3b). By
P7, ARIA was concentrated at synaptic sites, but intracellu-We and others have shown recently that ARIA is concen-
trated at synaptic sites in adult muscle ®bers (Chu et al., lar structures and extrasynaptic portions of the muscle ®ber
surface remained ARIA-positive (Fig. 3c). During the second1995a; Jo et al., 1995). At least some of this synaptic ARIA
is likely to be associated with nerve terminals, because postnatal week, the ratio of synaptic to extrasynaptic stain-
ing increased (Fig. 3d), until the adult pattern was achieved.ARIA-like immunoreactivity sometimes extended into
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dium, then fuse to form myotubes when refed with serum-
poor medium. Their advantage for the present purpose is
that they are a homogeneous cell type, whereas muscle con-
tains many cell types, including some (e.g., axons) that con-
tain ARIA. Accordingly, we puri®ed antibodies against the
bioactive peptide heregulin b1177±244 as previously described
(Chu et al., 1995a) and used them to probe extracts of Sol
8 myotubes and brain. The antibody recognized several spe-
cies in both tissues (Fig. 4a, 1). Preincubation of the antibody
with heregulin peptide abolished reactivity with the three
most prominent reactive proteins in muscle and the two
most prominent bands in brain, thereby identifying these
as ARIA-related (Fig. 4a, 2); preincubation with an unrelated
peptide had no effect (Fig. 4a, 3). One of the forms in Sol 8
cells was similar in size to the ARIA-polypeptide originally
isolated from chicken brain (42 kDa; Falls et al., 1993)
and to the predominant ARIA species in P7 rat muscle and
adult brain. A second ARIA species in Sol 8 cells (120
kDa) was present in brain but not neonatal muscle, while
a third species (58 kDa) was present in neither (Figs. 4a
and 4b).
Studies with recombinant fragments have shown that the
EGF-like domain in ARIA is crucial for its AChR-inducing
activity (Chu et al., 1995a). To learn whether muscle-de-
rived ARIA contains an intact EGF-like domain, we de-
signed PCR primers that spanned this domain, plus two
alternatively spliced regions, and used them to perform PCR
on cDNA from Sol 8 myotubes. The PCR products were
cloned and several clones were sequenced. Although the
clones differed at the a/b and 1±5 sites, all contained an
EGF-like domain and thus would be predicted to encode
active ARIA (Fig. 4c). Using the b1 fragment as a probe, we
found that ARIA RNA is present in muscle at birth (Fig.
4d, 1). ARIA levels increased during the ®rst postnatal week
(data not shown) and then declined during the subsequentFIG. 3. Muscle-derived perisynaptic deposits of ARIA in devel-
2 weeks to barely detectable levels in adults (Fig. 4d). Basedoping muscle. Sections of rat muscle were stained with antibodies
on these results, we conclude that muscle ®bers expressto recombinant heregulin (a±d) or with antisera to a heregulin-
derived peptide (e, f) and rhodamine-a-bungarotoxin (a*±f*) at P0 authentic ARIA in vivo.
(a), P4 (b), P7 (c, e, f), or P14 (d). For f, the anti-peptide antisera was
preincubated with the immunizing peptide. Arrows in (b), (c), and
Synaptic Localization of erbB2 and erbB3(e) indicate muscle ®ber cytoplasm immunoreactivity. Staining of
in Adult Musclemuscle ®ber cytoplasm and of nonmuscle cells between muscle
®bers (®broblasts and/or capillary endothelium) was more promi-
ErbB kinases are the only known receptors for ARIA/here-nent with the anti-peptide serum than with the anti-recombinant
gulin (Carraway and Cantley, 1994). We used speci®c anti-heregulin. Bar, 15 mm.
bodies to each of the four erbB kinases to assess their distri-
bution in adult muscle. Anti-EGFR stained interstitial areas
in a patchy pattern, presumably re¯ecting the presence of
EGFR on nonmuscle cells such as ®broblasts (Fig. 5a). Syn-Similar results were obtained with af®nity-puri®ed antisera
(not shown) and with antiserum directed against a peptide aptic sites were also sometimes EGFR-positive, but this
staining was dim and inconsistent. Likewise, muscle ®bersderived from the predicted intracellular domain of an ARIA/
heregulin precursor (Fig. 3e). Staining by the anti-peptide were stained weakly if at all by anti-erbB4 (Fig. 5d), even
though the antibody stained known erbB4-containing struc-antiserum was completely blocked by preincubation of the
antiserum with the peptide that had been used as immuno- tures in brain (not shown). In contrast, anti-erbB2 and anti-
erbB3 selectively stained synaptic sites on muscle ®bersgen (Fig. 3f).
These results suggested that muscle ®bers synthesize (Figs. 5b and 5c). Their distribution precisely overlapped
that of AChRs (Figs. 5b* and 5c*), indicating that the kinasesARIA. To test this possibility, we used the mouse muscle
cell line, Sol 8. Sol 8 cells grow as myoblasts in rich me- were associated with the postsynaptic membrane. Staining
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and 5f and data not shown). Identical results were obtained
with each of two anti-erbB3 antibodies, one of which recog-
nized an intracellular and the other an extracellular epitope
(see Methods). Thus, erbB2 and erbB3 are concentrated at
the neuromuscular junction.
As was the case for ARIA, we used Sol 8 cells to obtain
evidence that muscle cells generate authentic erbB kinases.
Using cRNA probes of similar length and speci®c activity,
we detected comparable levels of erbB2 and erbB3 RNA in
Sol 8 myotubes. No EGFR or erbB4 RNA was detected by
RNase protection (Fig. 6a), although low levels of EGFR (but
not erbB4) were detected by RT±PCR (not shown). Similar
RNase protection results were obtained using untreated and
ARIA-treated myotubes. EGFR and erbB4 were readily de-
tected in tissues previously shown to express these genes
(placenta and brain, respectively; Prigent et al., 1992; Plow-
man et al., 1993), ruling out the possibility that the probes
were defective. Thus, in vitro as in vivo, muscle cells ex-
press relatively high levels of erbB2 and erbB3 but little or
no EGFR or erbB4. Moreover, in that Sol 8 myotubes are
ARIA-responsive (Chu et al., 1995a), these results support
the notion that erbB2 and/or erbB3 are functional ARIA
receptors.
Based on these results, we immunoblotted extracts of Sol
8 myoblasts and myotubes with antibodies to erbB2 and
erbB3. In myotubes, both erbB2 and erbB3 antibodies recog-
nized proteins of 180±185 kDa, the expected sizes for these
erbB kinases (Fig. 6b). ErbB2 was present at similar levels
in myoblasts and myotubes, whereas erbB3 was detectable
only in myotubes. Staining was blocked by preincubation
of antisera with the immunizing peptide but not with a
noncognate peptide (not shown). Thus, whereas both erbB2
and erbB3 are candidate ARIA receptors in myotubes, erbB2
might mediate distinct effects of heregulins on myoblasts.FIG. 4. ARIA protein and mRNA expression in developing muscle
In addition to the 180-kDa protein, one of the anti-erbB3and Sol 8 cells. (a) Western blot analysis of Sol 8 myotube and mouse
antisera also recognized a 50 kDa protein in all tissuesbrain protein extracts (50 mg/lane). Panel 1 was probed with anti-here-
tested. Staining was blocked by the cognate peptide, indicat-gulin antibody. To identify speci®c bands, the anti-heregulin antibody
ing that this protein shares at least one epitope with erbB3.was preincubated with either the bioactive peptide HRGb1177-244 (panel
2) or with an irrelevant peptide (panel 3). Arrows on the left indicate However, the second, independently derived antiserum to
the speci®c heregulin peptides of 120, 58, and 42 kDa. The 58-kDa erbB3, which did stain synaptic sites, recognized the 180-
product (middle arrow) is present in myotubes but not brain. Molecular kDa but not the 50-kDa protein on immunoblots (not
weight markers are shown on the right. (b) Western blot of P7 rat shown). Therefore, we did not characterize the 50-kDa pro-
muscle extract (50 mg/lane) probed with anti-heregulin (lane 1) or anti- tein further.
heregulin that had been preincubated with the bioactive peptide (lane
2). (c) Heregulin RNAs cloned from Sol 8 myotubes. Heregulin tran-
scripts are alternatively spliced at several positions, as shown in the Distribution of erbB3 in Developing Muscle
diagram at the top (modi®ed from Ben-Baruch and Yarden, 1994). Prim-
For detailed studies of development and regulation, weers used to amplify cDNAs from Sol 8 cells are indicated. Three cDNAs
focused on erbB3. AChRs cluster on developing myotubesthat were cloned are shown. (d) RNase protection assays of postnatal
rat muscle, using the HRGb1 probe. A major protected fragment is by E14 (Chiu and Sanes, 1984), but erbB3 was not detectable
seen in P0 muscle and spinal cord (SC). Levels of RNA decrease by by our immuno¯uorescence method until the day of birth
P14. (Ð) lane, probe hybridized to yeast tRNA. (Figs. 7a and 7b). As soon as we could detect it at all, erbB3
protein was concentrated at synaptic sites. Staining of syn-
aptic sites became more intense during the ®rst postnatal
week, but no extrasynaptic staining was observed at any
age (Figs. 7c and 7d). The synaptic staining was speci®c inby antibodies to all four kinases was blocked by preincuba-
tion with the immunizing peptide but not with peptides that it was blocked by incubation of the antibody with the
immunizing peptide (Fig. 7e). Thus, erbB3 protein becomesthat had been used to generate other anti-erbB sera (Figs. 5e
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FIG. 5. Distribution of erbB proteins in adult rat muscle. Sections were incubated with speci®c antibodies to EGFR (a), erbB2 (b), erbB3
(c, e, f), or erbB4 (d). The sections were then stained with ¯uorescein-conjugated second antibodies (a±f) and rhodamine-a-bungarotoxin
(a*±f*). Staining by each antibody persisted in the presence of nonspeci®c peptide (for example, e, erbB3 Ab / erbB2 peptide) but was
inhibited by incubation with the peptide that had been used as immunogen (for example, f, erbB3 Ab / erbB3 peptide). Bar, 40 mm.
concentrated at the synapse perinatally, many days after
synapses form. This pattern stands in striking contrast to
that described above for ARIA (compare Figs. 3 and 7).
Because low levels of erbB3 immunoreactivity at early
stages might have escaped detection, we used the sensitive
RNase protection assay to ask whether erbB3 RNA was
present in embryos. In fact, erbB3 RNA was present in mus-
cle at E17 and its abundance changed little through the ®rst
postnatal week, as judged by normalization to the ubiqui-
tously expressed eEF1a mRNA (Fig. 7f). This result raises
the possibility that erbB3 protein is present but diffusely
distributed in embryonic muscle.
Mechanism of erbB3 Localization
AChRs become con®ned to the synaptic membrane as a
result of three mechanisms: selective transcription by syn-
aptic nuclei, activity-dependent repression of expression by
extrasynaptic nuclei, and clustering of diffuse receptors via
interactions with the cytoskeletal protein rapsyn (see Intro-
duction for references). We asked whether any of these
mechanisms could account for the synaptic localization of
FIG. 6. Expression of erbB family kinases in Sol 8 cells. (a) RNase erbB3.
protection analysis. Ten micrograms of RNA from Sol 8 cells or To seek selective transcription of erbB3 by synaptic nu-
placenta (plac) or 5 mg of brain RNA was hybridized with probes clei, we performed in situ hybridization on longitudinal sec-
of similar speci®c activities. Protected fragment sizes are: EGFR, tions of intercostal muscle, in which endplates form a nar-
328 bp; erbB2, 240 bp; erbB3, 350 bp; erbB4, 273 bp. Probes were row central band. The synaptic concentration of AChR e
hybridized to tRNA as a negative control. Sol 8 myotubes express subunit mRNA is readily detectable in such sections (Fig.
high levels of erbB2 and erbB3 and no detectable EGFR or erbB4
8b, middle; see Moscoso et al., 1995), but erbB3 RNA wasRNA. (b) Western blot analysis. Ten micrograms of Sol 8 myoblast
diffusely distributed in intercostal muscle (Fig. 8b, top). Inand myotube protein was probed with antibodies speci®c for erbB2
addition, we used RNase protection to assay synapse-freeor erbB3. The human breast carcinoma cell line, MDA-MB 453,
regions of diaphragm muscles, which are known to containwhich is known to express both erbB2 and erbB3 (Cailleau et al.,
1978), was used as a positive control (5 mg protein per lane). high and low levels, respectively, of AChR subunit mRNAs
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FIG. 8. Diffuse distribution of erbB3 RNA in adult muscle. (a)
Synapse-rich and synapse-free regions of adult muscle were dis-
sected and assayed for erbB3 by RNAse protection. Endplate-rich
regions of muscle were not signi®cantly enriched for erbB3 RNA.
(b) Sections of 3-week-old rat intercostal muscle hybridized with
erbB3 (top), AChR e subunit (middle), or control (laminin a1, bot-
tom) probes. m, muscle; r, rib. Similar results were obtained with
adult muscle. Autoradiograms on X-ray ®lm are shown.
12-day denervated muscle (Figs. 9b and 9c). These results
suggest that erbB3 expression is not highly activity-depen-
dent.
To ask whether erbB3 clustering is rapsyn-dependent, we
used a rapsyn-de®cient mutant mouse that we recently gen-
erated. These mice express AChRs at normal levels, but the
AChRs do not form synaptic clusters (Gautam et al., 1995).
The animals died a few hours after birth, by which time
erbB3 immunoreactivity was con®ned to synaptic sites in
wild-type mice (Fig. 10a). In mutants, in contrast, no high
FIG. 7. Distribution of erbB3 in developing muscle. Sections of
E18 (a), P0 (b, e), P7 (c), or P10 (d) rat muscle were doubly labeled
with anti-erbB3 (a±e) and rhodamine-a-bungarotoxin (a*±e*). ErbB3
was concentrated at synaptic sites as early as we could detect it.
Speci®c staining of erbB3 at early stages was con®rmed by staining
in the presence of speci®c blocking peptide (e). Bar, 15 mm. (f) ErbB3
RNA levels in developing muscle, assayed by RNase protections
in mouse muscle. Ten micrograms of muscle RNA was hybridized
with the erbB3 probe for each assay. Ages are as indicated above
each lane. The housekeeping gene eEF1a was used to control for
amounts of RNA.
(Merlie and Sanes, 1985). Levels of erbB3 RNA did not differ
signi®cantly between synaptic and nonsynaptic regions
(Fig. 8a). Thus, erbB3 does not appear to become spatially
restricted via a local transcription mechanism.
To ask whether activity represses erbB3 expression, we
examined denervated muscle. ErbB3 mRNA levels changed
FIG. 9. ErbB3 RNA levels and protein localization change little
little during the ®rst 4 days after nerve section (Fig. 9a), a following denervation. (a) RNA levels of erbB3 in 4- and 10-day
time at which AChR subunit mRNA levels had increased denervated rat muscle assayed by RNase protection. (b, c) Adult
nearly 100-fold (Merlie et al., 1984). Even after an additional rat muscles doubly labeled with anti-erbB3 and rhodamine bungar-
week, erbB3 levels changed only a fewfold. Likewise, no otoxin, 2 (b) or 12 (c) days after nerve section. Brightly stained
endplates are observed at both times. Bar, 40 mm.erbB3 protein was detectable in extrasynaptic areas of 2- or
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FIG. 10. Distribution of erbB3 protein in rapsyn-de®cient muscle from P0 control (a) and mutant (b) mice were labeled with anti-erbB3
(a*, b*) and antibodies to the synaptic vesicle protein SV2 (a*, b*). ErbB3 is not clustered at synaptic sites in the absence of rapsyn. Bar, 10
mm. (c) Immunoblot analysis of muscles from control and rapsyn mutant mice, probed with anti-erbB3 in the absence or presence of the
immunizing peptide.
density clusters of the erbB3 protein were detected at syn- tic sites. Third, the distribution of erbB3 is regulated by
rapsyn and, by implication, agrin. Finally, levels of bothapses (Fig. 10b). (Synapses were marked with SV2 in these
studies, because AChR clusters were absent; see Fig. 2a.) ARIA and erbB3 increase markedly in synaptic regions peri-
natally, several days after synaptic nuclei become transcrip-Western blot analysis showed that similar levels of erbB3
protein were present in mutant animals and littermate con- tionally specialized.
trols (Fig. 10c). These results provide genetic evidence that
rapsyn is not required for erbB3 gene expression, but does
Muscle-Derived ARIAplay a critical role in localizing erbB3 protein to the synapse.
In contrast, erbB3 was normally localized in mutant mice Most of the intramuscular ARIA immunoreactivity we
detect during early postnatal development is associatedlacking the basal lamina protein s-laminin/laminin b2
(Noakes et al., 1995; data not shown). with myotubes rather than nerve terminals and is not re-
stricted to synaptic sites. ARIA RNA is also present in mus-
cles, arguing against the possibility that the protein is syn-
thesized in motoneuronal somata and subsequently trans-DISCUSSION
ferred from nerves to myotubes. In addition, cultured
myotubes accumulate ARIA protein and RNA, demonstra-ARIA was discovered in a search for nerve-derived factors
that stimulate muscle cells to synthesize AChRs (Usdin ting that ARIA is made by muscle ®bers, rather than (or in
addition to) other intramuscular cells, such as ®broblastsand Fischbach, 1986). Molecular cloning revealed that ARIA
is encoded by the same gene that generates heregulin/NDF or Schwann cells. Whether the muscle contributes ARIA to
the synaptic site per se is unknown, but a recent observation(Holmes et al., 1992; Wen et al., 1992). Motoneuronal so-
mata contain ARIA mRNA (Falls et al., 1993; Marchionni by Jo et al. (1995) suggests that it might: they showed that
levels of ARIA immunoreactivity at synaptic sites wereet al., 1993), and ARIA protein is concentrated at synaptic
sites in adult muscle (Chu et al., 1995a; Jo et al., 1995). higher in denervated muscle than in basal lamina ``ghosts''
that survived damage to the muscle as well as to the nerve.Studies of cultured cells showed that heregulin is a ligand
for the erbB family of receptor tyrosine kinases (Plowman Thus, some of the synaptic ARIA in adult muscle might be
associated with the muscle membrane.et al., 1993b; Carraway et al., 1994; Sliwkowski et al., 1994;
Tzahar et al., 1994; reviewed in Carraway and Cantley, How could nerves use ARIA as a synaptic signal in the
face of an excess of muscle-derived ARIA? We can envision1994) and that myotubes contain functional erbB kinases
(Jo et al., 1995; see also Corfas et al., 1993). A plausible several alternatives. One is that the muscle-derived ARIA
is intracellular and has no access to its receptors, whichhypothesis, therefore, is that developing motor axons re-
lease ARIA onto erbB-bearing myotubes, resulting in gener- face outwards. This seems unlikely, both because we detect
surface-associated ARIA on myotubes and because only aation of a local signal that induces transcription of AChR
subunit genes by subsynaptic nuclei. In the studies reported tiny fraction of the muscle ARIA would need to be released
to exceed a neural contribution. Second, axonal ARIA mighthere, we asked whether ARIA and erbB kinases are ex-
pressed at times and places consistent with this hypothesis. induce expression of muscle ARIA, which would then am-
plify the signal. Indirect evidence against this possibility isOur tentative answer is ``yes,'' but this af®rmation is quali-
®ed by several unexpected results. First, much of the ARIA the ®nding that application of recombinant ARIA does not
signi®cantly affect the levels of ARIA RNA or protein inin developing muscle is made by the muscle ®ber. Second,
both erbB2 and erbB3 are (or become) concentrated at synap- Sol 8 cells (unpublished data). Third, muscle ARIA might
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be biologically inactive. In fact, this explanation is now aptic sites in embryos (g subunit; G.C.C. and J.P.M., unpub-
lished) or by birth (d subunit; Simon et al., 1992). We ®ndfavored for agrin, a nerve-derived signal that induces AChR
clustering (McMahan, 1990). Alternative splicing generates that erbB3 is not detectably concentrated at synaptic sites
in embryos (Fig. 7) and that synaptic nuclei (marked by aseveral agrin RNAs, only some of which encode biologically
active protein. Most of the agrin in developing muscles is g-lacZ transgene) became transcriptionally specialized in
rapsyn-de®cient mice (Gautam et al., 1995), which lacksynthesized by the myotubes rather than by the motoneu-
rons, but only the neurons express the ``active'' forms (Bowe clustered erbB3 (Fig. 10). Thus, synaptic accumulations of
erbB3 are not required for the initial speci®cation of synap-and Fallon, 1995). Similarly, the ARIA gene is alternatively
spliced to generate numerous RNAs, and although our PCR tic nuclei. Evidently, either diffusely distributed erbB3
(which may be present at levels below the sensitivity ofanalysis indicates that muscle ARIA encodes the domains
required for biological activity (Holmes et al., 1992), it may our immuno¯uorescence method) is suf®cient, or another
receptor is involved.contain additional sequences or modi®cations that render
it incapable of inducing AChR synthesis. During the ®rst 2 postnatal weeks, synaptic nuclei cease
expressing the AChR g subunit gene and dramatically in-Finally, it is possible that the nerve uses a distinct signal
to induce expression of muscle ARIA, and ARIA subse- crease expression of the AChR e subunit gene, resulting in
a replacement of fetal AChRs (subunit composition a2bgd)quently induces AChR expression by an autocrine mecha-
nism. In this context, it is noteworthy that Avila et al. by adult AChRs (a2bed; Hall and Sanes, 1993; Chu et al.,
1995b). Synaptic nuclei begin to express the AChR e subunit(1995) recently demonstrated autocrine control of prolifera-
tion in a neoplastic cell line by ARIA/NDF and erbB2. gene on schedule following neonatal denervation (Brenner
et al., 1990; Gundersen et al., 1993), indicating that subunit
switching does not require the continuous presence of the
Synaptic Localization of erbB2 and erbB3 nerve. Instead, it has been hypothesized that the nerve de-
posits a local ``trace,'' perhaps in the basal lamina (GoldmanAxons can form synapses on any part of the myotube
surface (Hall and Sanes, 1993), so one might expect that the et al., 1991; Jo and Burden, 1992; Brenner et al., 1992), that
``imprints'' synaptic nuclei. Whether the subunit switchlocation of the postsynaptic site would be determined by a
localized, nerve-derived signal acting on a uniformly distrib- re¯ects a distinct effect of the trace or an endogenous matu-
ration remains unclear. In this context, it is interesting thatuted postsynaptic receptor. Such a mechanism would be
analogous to several that have been studied in other sys- synaptic deposits of erbB3 and extrasynaptic accumulations
of ARIA appear in muscle ®bers during the time that thetems. In the Drosophila embryo, for example, the establish-
ment of dorsoventral polarity is triggered by the binding of g-to-e switch occurs. This correlation invites the specula-
tion that muscle ARIA and clustered erbB3 play a role ina ventrally produced ligand, SpaÈtzle, to a uniformly distrib-
uted receptor, Toll (Roth, 1994). In contrast, the putative the subunit switch. The observations that ARIA induces
expression of the AChR e subunit 10-fold, while inducingreceptor erbB3 is more tightly restricted to synaptic sites
than is its ligand, ARIA, in neonatal animals. the AChR a, b, g, and d subunits£2-fold in cultured muscle
(Martinou et al., 1991; Chu et al., 1995a; Jo et al., 1995), isThese observations raise the possibility that the spatial
restriction of the ARIA signaling pathway involves localiza- consistent with this idea. One intriguing possibility is that
a predominant role of the nerve-derived ``trace'' might betion of the receptor as well as of the ligand. It was therefore
intriguing to ®nd that the restriction of erbB3 to synaptic to localize erbB3 kinases by a rapsyn/agrin-dependent
mechanism, thus localizing the e-inducing effects of mus-sites is rapsyn-dependent. Clustering of AChRs in the sub-
synaptic membrane, which is triggered by nerve-derived fac- cle-derived ARIA.
tors such as agrin, requires rapsyn: forced expression of
rapsyn causes recombinant AChRs to cluster in cultured
cells (Apel and Merlie, 1995), and mutation of the Rapsn ACKNOWLEDGMENTS
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